GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
Clinical trial NCT04622956 · UNKNOWN
Trial details
- NCT number
- NCT04622956
- Sponsor
- University of Sao Paulo General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2023-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.